David Shapiro
Director/Board Member chez GALECTO, INC.
Fortune : - $ au 31/03/2024
Profil
David A.
Shapiro is the founder of Integrated Quality Resources, Inc. founded in 1998, where he holds the title of President & Chief Executive Officer.
Currently, he holds the position of Independent Director at Galecto, Inc. since 2020, Director at Yaqrit Discovery Ltd., and Member at The Royal College of Physicians.
In the past, he held the position of Independent Director at Organovo Holdings, Inc. from 2018 to 2020, Director at Altair Therapeutics, Inc., Independent Director at Arcturus Therapeutics Ltd.
from 2017 to 2018, Chief Medical Officer & EVP-Medical Affairs at Idun Pharmaceuticals, Inc. from 2000 to 2005, Chief Medical Officer at Intercept Pharmaceuticals, Inc. from 2017 to 2019, Vice President-Clinical Research at Gensia Pharmaceuticals, Inc. from 1985 to 1990, and Principal at Organon Pharma (UK) Ltd.
from 1985 to 1990.
He was also a Trustee & Vice President at American Academy of Pharmaceutical Physicians and President-Scripps Medical Research Center at Scripps Clinic Medical Group, Inc. from 1995 to 1998.
Dr. Shapiro received a doctorate degree from the University of Dundee School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GALECTO, INC.
-.--% | 14/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de David Shapiro
| Sociétés | Poste | Début |
|---|---|---|
| GALECTO, INC. | Director/Board Member | 19/05/2020 |
| The Royal College of Physicians | Corporate Officer/Principal | - |
| Integrated Quality Resources, Inc. | Chief Executive Officer | 01/01/1998 |
Yaqrit Discovery Ltd.
 Yaqrit Discovery Ltd. Hospital/Nursing ManagementHealth Services Yaqrit Discovery Ltd is a British company that focuses on advancing the treatment of liver disease. The company is based in Ledbury, UK and has subsidiaries in the United Kingdom. Green. Yaqrit Discovery Ltd was founded in 2001 by Rajiv Jalan and the CEO is Daniel J. | Director/Board Member | - |
Anciens postes connus de David Shapiro
| Sociétés | Poste | Fin |
|---|---|---|
| ORGANOVO HOLDINGS, INC. | Director/Board Member | 14/07/2020 |
| INTERCEPT PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/05/2019 |
Arcturus Therapeutics Ltd.
 Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics Ltd. engages in the provision of RNA medicines, which focuses on liver and respiratory diseases. Its RNA medicines include mRNA; siRNA, miRNA, and ASO;, CRISPR, TALEN, and meganucleases; and Replicon RNA and DNA. The company was founded by Joseph Payne in March 2013 and is headquartered in San Diego, CA. | Director/Board Member | 27/05/2018 |
Altair Therapeutics, Inc.
 Altair Therapeutics, Inc. Medical DistributorsDistribution Services Altair is a privately owned company that was spun out of ISIS Pharmaceuticals in October 2007 with the objective of applying ISIS’s proprietary second generation (2’-MOE Gapmer) antisense oligoneucleotide technology to the field of inhaled therapeutics. Through its collaboration with ISIS Altair has access to both near term clinical stage opportunities, as well as early stage development projects. Altair's first compound AIR645 is currently in phase I clinical trials. This first in class compound posses unique anti-inflammatory activities appropriate for multiple therapeutic applications, including asthma, rhinitis and COPD. Additionally, the characteristics of the 2'-MOE Gapmer chemistry provides for the possibility of administration of AIR645 as an inhaled therapeutic delivered once weekly. Altair is also planning on developing a future pipeline of other best-in-class molecules for respiratory targets by exploiting the advantages of its propriety 2nd generation antisense oligonucleotide chemistry. | Director/Board Member | 09/03/2011 |
Idun Pharmaceuticals, Inc.
 Idun Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Idun Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the discovery and development of human therapeutics to control apoptosis. The company was founded by John C. Reed, Robert H. Horvitz, and Lawrence C. Fritz in March 1993 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | - |
Formation de David Shapiro
| University of Dundee School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
| ORGANOVO HOLDINGS, INC. | Health Technology |
| GALECTO, INC. | Health Technology |
| Entreprise privées | 10 |
|---|---|
Idun Pharmaceuticals, Inc.
Idun Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Idun Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the discovery and development of human therapeutics to control apoptosis. The company was founded by John C. Reed, Robert H. Horvitz, and Lawrence C. Fritz in March 1993 and is headquartered in San Diego, CA. | Health Technology |
Gensia Pharmaceuticals, Inc.
 Gensia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gensia Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products for cardiovascular diseases. The company is based in San Diego, CA and has subsidiaries in the United States. The company was founded by Robert L. Engler, Paul K. Laikind. | Health Technology |
Organon Pharma (UK) Ltd.
 Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Health Technology |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Health Technology |
| American Academy of Pharmaceutical Physicians | |
| Scripps Clinic Medical Group, Inc. | |
Altair Therapeutics, Inc.
Altair Therapeutics, Inc. Medical DistributorsDistribution Services Altair is a privately owned company that was spun out of ISIS Pharmaceuticals in October 2007 with the objective of applying ISIS’s proprietary second generation (2’-MOE Gapmer) antisense oligoneucleotide technology to the field of inhaled therapeutics. Through its collaboration with ISIS Altair has access to both near term clinical stage opportunities, as well as early stage development projects. Altair's first compound AIR645 is currently in phase I clinical trials. This first in class compound posses unique anti-inflammatory activities appropriate for multiple therapeutic applications, including asthma, rhinitis and COPD. Additionally, the characteristics of the 2'-MOE Gapmer chemistry provides for the possibility of administration of AIR645 as an inhaled therapeutic delivered once weekly. Altair is also planning on developing a future pipeline of other best-in-class molecules for respiratory targets by exploiting the advantages of its propriety 2nd generation antisense oligonucleotide chemistry. | Distribution Services |
| Integrated Quality Resources, Inc. | |
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics Ltd. engages in the provision of RNA medicines, which focuses on liver and respiratory diseases. Its RNA medicines include mRNA; siRNA, miRNA, and ASO;, CRISPR, TALEN, and meganucleases; and Replicon RNA and DNA. The company was founded by Joseph Payne in March 2013 and is headquartered in San Diego, CA. | Health Technology |
Yaqrit Discovery Ltd.
Yaqrit Discovery Ltd. Hospital/Nursing ManagementHealth Services Yaqrit Discovery Ltd is a British company that focuses on advancing the treatment of liver disease. The company is based in Ledbury, UK and has subsidiaries in the United Kingdom. Green. Yaqrit Discovery Ltd was founded in 2001 by Rajiv Jalan and the CEO is Daniel J. | Health Services |
